台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

(LS8-1) Optimize the treatment landscape of ADC in metastatic urothelial carcinoma_蘇柏榮

2024-09-08 • 觀看: 7 • 回應: 0 • 影片
(LS3-1) How to optimize mRCC treatment under current treatment landscape_陳忠信

2024-09-08 • 觀看: 4 • 回應: 0 • 影片
(SF4-8) Application of AI in urology_甘弘成

2024-09-08 • 觀看: 3 • 回應: 0 • 影片
(IS6-1) Exploring the efficacy of denosumab in preventing SREs in prostate cancer patients with bone metastasis_陳卷書

2024-09-08 • 觀看: 30 • 回應: 0 • 影片
(TSQ-4) 健保各領域申請及討論 - 新創_王炯珵

2024-09-08 • 觀看: 4 • 回應: 0 • 影片
(LS7-1) Why Ultra-Low PSA Matters Clinical Benefits of Apalutamide Plus ADT in mCSPC_Axel Merseburger

2024-09-08 • 觀看: 9 • 回應: 0 • 影片
(IS4-2) The added value of phi on the selection of candidates for focal therapy of prostate cancer_李宗叡

2024-09-08 • 觀看: 7 • 回應: 0 • 影片
(IS3-2) Candidates suitable for Allium® ureteral stents_魏子鈞

2024-09-08 • 觀看: 7 • 回應: 0 • 影片
(IS4-1) 沒有最好只有最適合 2024年台灣精準攝護腺癌診斷的健保新進展：攝護腺健康指數 Prostate Health Index_蔣智宏

2024-09-08 • 觀看: 14 • 回應: 0 • 影片
(IS3-1) Sharing for treatment of refractory ureteral stricture by Allium® ureteral stents_王炯珵

2024-09-08 • 觀看: 14 • 回應: 0 • 影片
(IS2-2) Applications and efficacy of top flat magnetic stimulation (TOP FMS) for pelvic floor dysfunction_張博誌

2024-09-08 • 觀看: 7 • 回應: 0 • 影片
(IS2-1) A fractional CO2 vaginal laser in treating women's stress urinary incontinence(SUI) Experiences sharing_黃煒軒

2024-09-08 • 觀看: 11 • 回應: 0 • 影片

Prev
77
78
79
80
81
82
83
84
85
86
Next
/ 1052